Serum sclerostin in rheumatoid-induced osteoporosis
Abstract Background Rheumatoid arthritis (RA) is characterized by presence of localized and generalized osteoporosis. The mechanism of decreased bone mass is complex and multifactorial, a possible mechanism behind increased bone loss in RA is upregulation of sclerostin. The aim of this work was to e...
Main Authors: | Ola Gharbia, Aliaa Hegazy, Rania Elhelaly, Atif ElGhaweet |
---|---|
Format: | Article |
Language: | English |
Published: |
SpringerOpen
2020-07-01
|
Series: | Egyptian Rheumatology and Rehabilitation |
Subjects: | |
Online Access: | https://doi.org/10.1186/s43166-020-00015-4 |
Similar Items
-
Type 2 diabetes raises serum sclerostin levels and disturbs the relation between sclerostin and bone mineral density: a call for caution with antisclerostin therapy in osteoporosis
by: Dina S Al-Zifzaf, et al.
Published: (2014-01-01) -
Serum Sclerostin Level Among Egyptian Rheumatoid Arthritis Patients: Relation to Disease Activity ,Bone Mineral Density and Radiological Grading
by: Dina Ahmed Mehaney, et al.
Published: (2015-07-01) -
Anti-Sclerostin Antibodies in Osteoporosis and Other Bone Diseases
by: Stéphanie Fabre, et al.
Published: (2020-10-01) -
Prevalence of low bone mineral density in ankylosing spondylitis, correlation with disease activity, and serum sclerostin levels
by: Anupam Wakhlu, et al.
Published: (2020-01-01) -
Profile of romosozumab and its potential in the management of osteoporosis
by: Lim SY, et al.
Published: (2017-04-01)